chr19-50309767-T-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001145809.2(MYH14):​c.6088T>A​(p.Ser2030Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000704 in 1,419,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S2030S) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

MYH14
NM_001145809.2 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: -0.00400

Publications

0 publications found
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
MYH14 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 4A
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.073987246).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH14NM_001145809.2 linkc.6088T>A p.Ser2030Thr missense_variant Exon 43 of 43 ENST00000642316.2 NP_001139281.1 Q7Z406-2A1L2Z2B3KWH4
MYH14NM_001077186.2 linkc.5989T>A p.Ser1997Thr missense_variant Exon 42 of 42 NP_001070654.1 Q7Z406-6B3KWH4
MYH14NM_024729.4 linkc.5965T>A p.Ser1989Thr missense_variant Exon 41 of 41 NP_079005.3 Q7Z406-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH14ENST00000642316.2 linkc.6088T>A p.Ser2030Thr missense_variant Exon 43 of 43 NM_001145809.2 ENSP00000493594.1 Q7Z406-2

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD2 exomes
AF:
0.00000502
AC:
1
AN:
199316
AF XY:
0.00000929
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000116
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.04e-7
AC:
1
AN:
1419508
Hom.:
0
Cov.:
35
AF XY:
0.00000142
AC XY:
1
AN XY:
703836
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32410
American (AMR)
AF:
0.00
AC:
0
AN:
40320
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25208
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37470
South Asian (SAS)
AF:
0.0000122
AC:
1
AN:
81656
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50442
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5682
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1087792
Other (OTH)
AF:
0.00
AC:
0
AN:
58528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
30

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 12, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Benign. The Ser2030Thr vari ant in MYH14 has not been previously reported in individuals with hearing loss o r in large population studies. Computational analyses (biochemical amino acid pr operties, conservation, AlignGVGD, PolyPhen2, and SIFT) suggest that the Ser2030 Thr variant may not impact the protein, though this information is not predictiv e enough to rule out pathogenicity. In summary, the clinical significance of thi s variant cannot be determined with certainty; however based upon the conservati on and computational data, we would lean towards a more likely benign role. -

not provided Uncertain:1
Jan 01, 2018
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.086
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
13
DANN
Benign
0.87
DEOGEN2
Benign
0.087
.;.;.;T;.;.;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.55
.;T;T;T;.;T;.
M_CAP
Benign
0.076
D
MetaRNN
Benign
0.074
T;T;T;T;T;T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
1.1
.;.;.;L;.;.;L
PhyloP100
-0.0040
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.11
.;.;N;.;.;.;.
REVEL
Benign
0.14
Sift
Benign
0.045
.;.;D;.;.;.;.
Sift4G
Benign
0.42
T;T;T;T;.;T;T
Polyphen
0.0020
B;.;B;B;B;B;B
Vest4
0.15
MutPred
0.20
.;.;.;Gain of relative solvent accessibility (P = 0.1259);.;.;Gain of relative solvent accessibility (P = 0.1259);
MVP
0.54
MPC
0.14
ClinPred
0.042
T
GERP RS
-1.8
Varity_R
0.039
gMVP
0.40
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727503231; hg19: chr19-50813024; API